Analyst Price Targets — ACR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 31, 2025 10:01 am | — | JMP Securities | $24.50 | $20.80 | TheFly | ACRES Commercial Realty Corp. price target raised to $24.50 from $23.50 at Citizens JMP |
| September 25, 2024 6:27 am | Chris Muller | JMP Securities | $17.50 | $15.82 | TheFly | ACRES Commercial Realty Corp. price target raised to $17.50 from $16.50 at JMP Securities |
| July 18, 2022 8:04 am | — | Raymond James | $15.00 | $7.85 | Benzinga | Raymond James Maintains Outperform on ACRES Commercial Realty, Lowers Price Target to $15 |
| July 14, 2022 7:52 am | — | JMP Securities | $14.00 | $8.27 | Benzinga | JMP Securities Maintains Market Outperform on ACRES Commercial Realty, Lowers Price Target to $14 |
| May 18, 2022 8:26 am | — | Raymond James | $18.50 | $11.06 | Benzinga | Raymond James Maintains Outperform on ACRES Commercial Realty, Lowers Price Target to $18.5 |
Latest News for ACR
UNIONDALE, N.Y., July 15, 2026 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) (the "Company") announced today that it will release its results for the second quarter 2026, on Wednesday, July 29, 2026, after the market closes.
Acrivon Therapeutics (ACRV) trades below cash value, with the market deeply discounting its platform and pipeline despite promising early data. ACRV's AP3 platform enables precision patient-matching for kinase inhibitor therapies, showing a 50% response rate in serous endometrial cancer with ACR-368. Key near-term catalysts include Phase 2b ACR-368 data and Phase 1 ACR-2316 expansion results, both critical for…
GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh
UNIONDALE, N.Y., May 27, 2026 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) (the "Company") announced today that its Board of Directors declared cash dividends on its Preferred Stock.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ACR.
U.S. House Trading
No House trades found for ACR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.